SRPT BREAKING NEWS: Sarepta Therapeutics, Inc. is being Investigated for Securities Fraud after Second Elevidys Death; Investors with Losses are Notified to Contact BFA Law
NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Sarepta Therapeutics, Inc. (NASDAQ: SRPT) for potential violations of the federal securities laws.
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Sarepta Therapeutics, Inc. (NASDAQ: SRPT) for potential violations of the federal securities laws.
Share
If you invested in Sarepta, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/sarepta-therapeutics-inc-class-action.
Why is Sarepta being Investigated?
Sarepta is a biopharmaceutical company focused on developing treatments for rare diseases. Sarepta's most important product is Elevidys, a therapy for the treatment of Duchenne muscular dystrophy. During the relevant period, Sarepta repeatedly touted the safety profile of Elevidys and told investors that the benefits of the treatment outweighed its risks. In truth, Elevidys causes fatal acute liver failure in some patients.
The Stock Declines as the Truth is Revealed
On March 18, 2025, Sarepta announced that a patient that had been treated with Elevidys died after suffering acute liver failure. On this news, the price of Sarepta stock fell $27.81 per share, or over 27%, from $101.35 per share on March 17, 2025, to $73.54 per share on March 18, 2025. Nevertheless, on the same day, Sarepta assured investors that 'the benefit-risk of ELEVIDYS remains positive.'
Next, on June 15, 2025, Sarepta announced that a second patient treated with Elevidys had died from acute liver failure. The company further announced that because of the second death, it was suspending certain shipments of Elevidys and paused dosing in an ongoing clinical trial of the treatment. On this news, the price of Sarepta stock fell $15.24 per share, or more than 42%, from $36.18 per share on June 13, 2025, to $20.94 per share on June 16, 2025.
Click here for more information: .
What Can You Do?
If you invested in Sarepta you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs' Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
Attorney advertising. Past results do not guarantee future outcomes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
29 minutes ago
- USA Today
US stock futures higher ahead of Fed interest rate announcement
US stock futures higher ahead of Fed interest rate announcement Show Caption Hide Caption Trump threatens Iran's leader in bid to halt strikes President Donald Trump threatened Iran's supreme leader with assassination as he pushed Tehran to end its retaliatory airstrikes on Israel. U.S. stock futures are higher ahead of the Federal Reserve's interest rate announcement this afternoon. The Fed is expected to hold rates steady as it continues to observe the effects of President Donald Trump's tariffs. So far, tariffs haven't boosted inflation much and the job market has slowed, but not cratered, giving the Fed time to take a wait-and-see approach to tariffs and now the Israel-Iran conflict. Since Israel attacked Iran, oil prices have jumped to a near five-month high. Much of the world's oil comes from the Middle East, and if oil prices continue to climb or stay elevated for a while, that could ignite inflation. Along with the Fed's policy announcement, central bankers will release their economic forecasts. Economists expect the Fed to raises its inflation outlook, lower its economic growth forecast and keep the unemployment rate fairly low. Investors will also be looking to see how many rate cuts the Fed expects to implement this year and next. At 6:10 a.m. ET, futures linked to the blue-chip Dow rose 0.21%, while broad S&P 500 futures gained 0.27% and tech-laden Nasdaq futures added 0.35%. Cryptocurrency The Senate passed to regulate stablecoins, or a type of cryptocurrency designed to maintain a stable price, often by being pegged to a more stable asset like the U.S. dollar. The Senate's legislation requires dollar-pegged stablecoins to hold dollar-for-dollar reserves in short-term government debt or similar products overseen by state or federal regulators. The bill now goes to the House, which must decide whether it will take up the bill or negotiate a compromise. Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@ and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday.
Yahoo
30 minutes ago
- Yahoo
Reliance Global Group signs LoI for Fortman Insurance sale
Reliance Global Group, an AI-powered insurtech company, has signed a non-binding letter of intent (LOI) to divest Fortman Insurance Agency, its fully owned unit. The proposed sale price is $5m in cash, which indicates a 'meaningful premium' over the original acquisition cost. This LoI remains non-binding, and is subject to due diligence and negotiation of definitive documentation. The insurtech company said it has modernised Fortman's internal systems and made operational improvements since it acquired the business. This has resulted in a 'well-capitalised' business with an increasing customer base and wider market reach, the Nasdaq-listed company added. The proceeds from the sale are expected to support Reliance's planned purchase of insurance platform Spetner Associates. In recent years, Spetner is said to have demonstrated 'robust growth' and is projected to generate 'strong cash flow' for both the subsidiary and parent company. Reliance anticipates that Spetner will integrate 'seamlessly' into its operations under the OneFirm strategy. Reliance Global Group CEO Ezra Beyman said: 'The potential sale of Fortman demonstrates our disciplined capital allocation strategy and commitment to value creation. We acquired Fortman at a compelling valuation, strengthened its operations and are now positioned to realise a meaningful return. 'This contemplated transaction reflects our ability to execute and supports our broader goal of building a highly profitable and focused organisation. 'Not only does the sale price represent a premium to what we paid for Fortman, but it also adds substantial cash to our balance sheet – an especially notable achievement in light of our current market capitalisation.' "Reliance Global Group signs LoI for Fortman Insurance sale" was originally created and published by Life Insurance International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
US stock futures higher ahead of Fed interest rate announcement
U.S. stock futures are higher ahead of the Federal Reserve's interest rate announcement this afternoon. The Fed is expected to hold rates steady as it continues to observe the effects of President Donald Trump's tariffs. So far, tariffs haven't boosted inflation much and the job market has slowed, but not cratered, giving the Fed time to take a wait-and-see approach to tariffs and now the Israel-Iran conflict. Since Israel attacked Iran, oil prices have jumped to a near five-month high. Much of the world's oil comes from the Middle East, and if oil prices continue to climb or stay elevated for a while, that could ignite inflation. Along with the Fed's policy announcement, central bankers will release their economic forecasts. Economists expect the Fed to raises its inflation outlook, lower its economic growth forecast and keep the unemployment rate fairly low. Investors will also be looking to see how many rate cuts the Fed expects to implement this year and next. At 6:10 a.m. ET, futures linked to the blue-chip Dow rose 0.21%, while broad S&P 500 futures gained 0.27% and tech-laden Nasdaq futures added 0.35%. The Senate passed to regulate stablecoins, or a type of cryptocurrency designed to maintain a stable price, often by being pegged to a more stable asset like the U.S. dollar. The Senate's legislation requires dollar-pegged stablecoins to hold dollar-for-dollar reserves in short-term government debt or similar products overseen by state or federal regulators. The bill now goes to the House, which must decide whether it will take up the bill or negotiate a compromise. Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@ and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday. This article originally appeared on USA TODAY: US stock futures higher ahead of Fed interest rate announcement Sign in to access your portfolio
